Amy Leung1, Rama Natarajan. 1. Department of Diabetes, Beckman Research Institute of the City of Hope, Duarte, California, USA.
Abstract
PURPOSE OF REVIEW: Noncoding RNAs (ncRNAs) have gained the attention of molecular biologists and clinicians alike because of the increasing evidence implicating their role in many biological processes and in the development of diseases. In addition to small microRNAs (miRNAs) that play major roles in the post-transcriptional regulation of gene expression, more recently long ncRNAs (lncRNAs, >200 nucleotides) are recognized as being intimately involved in the key cellular processes including transcription and mRNA expression, and having functions in cellular development, differentiation, and development of disease. LncRNAs represent a diverse class of RNAs with many known and likely yet to be discovered functions. This review aims to summarize the emerging roles of lncRNAs in vascular development and disease. RECENT FINDINGS: LncRNAs have been recently described to play a role in vascular development, lineage commitment, and in mesoderm differentiation into heart. Additionally, lncRNAs have been associated with angiotensin II actions and with vascular diseases, including coronary heart disease and atherosclerosis. miRNAs, well studied in various vascular diseases, have also been recently shown to be differentially expressed in the biofluids of patients with vascular disease and mediate cell-cell communication. SUMMARY: LncRNAs may mediate many different pathways in growth factor actions, vascular development and disease, and are worthy of further investigation because of their potential to serve as novel therapeutic targets.
PURPOSE OF REVIEW: Noncoding RNAs (ncRNAs) have gained the attention of molecular biologists and clinicians alike because of the increasing evidence implicating their role in many biological processes and in the development of diseases. In addition to small microRNAs (miRNAs) that play major roles in the post-transcriptional regulation of gene expression, more recently long ncRNAs (lncRNAs, >200 nucleotides) are recognized as being intimately involved in the key cellular processes including transcription and mRNA expression, and having functions in cellular development, differentiation, and development of disease. LncRNAs represent a diverse class of RNAs with many known and likely yet to be discovered functions. This review aims to summarize the emerging roles of lncRNAs in vascular development and disease. RECENT FINDINGS: LncRNAs have been recently described to play a role in vascular development, lineage commitment, and in mesoderm differentiation into heart. Additionally, lncRNAs have been associated with angiotensin II actions and with vascular diseases, including coronary heart disease and atherosclerosis. miRNAs, well studied in various vascular diseases, have also been recently shown to be differentially expressed in the biofluids of patients with vascular disease and mediate cell-cell communication. SUMMARY: LncRNAs may mediate many different pathways in growth factor actions, vascular development and disease, and are worthy of further investigation because of their potential to serve as novel therapeutic targets.
Authors: Anke J Tijsen; Esther E Creemers; Perry D Moerland; Leon J de Windt; Allard C van der Wal; Wouter E Kok; Yigal M Pinto Journal: Circ Res Date: 2010-02-25 Impact factor: 17.367
Authors: Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F Lin; David Feldser; Maite Huarte; Or Zuk; Bryce W Carey; John P Cassady; Moran N Cabili; Rudolf Jaenisch; Tarjei S Mikkelsen; Tyler Jacks; Nir Hacohen; Bradley E Bernstein; Manolis Kellis; Aviv Regev; John L Rinn; Eric S Lander Journal: Nature Date: 2009-02-01 Impact factor: 49.962
Authors: Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn Journal: Proc Natl Acad Sci U S A Date: 2009-07-01 Impact factor: 11.205
Authors: Teri A Manolio; Francis S Collins; Nancy J Cox; David B Goldstein; Lucia A Hindorff; David J Hunter; Mark I McCarthy; Erin M Ramos; Lon R Cardon; Aravinda Chakravarti; Judy H Cho; Alan E Guttmacher; Augustine Kong; Leonid Kruglyak; Elaine Mardis; Charles N Rotimi; Montgomery Slatkin; David Valle; Alice S Whittemore; Michael Boehnke; Andrew G Clark; Evan E Eichler; Greg Gibson; Jonathan L Haines; Trudy F C Mackay; Steven A McCarroll; Peter M Visscher Journal: Nature Date: 2009-10-08 Impact factor: 49.962
Authors: Eric Pasmant; Ingrid Laurendeau; Delphine Héron; Michel Vidaud; Dominique Vidaud; Ivan Bièche Journal: Cancer Res Date: 2007-04-15 Impact factor: 12.701
Authors: Lasse Folkersen; Theodosios Kyriakou; Anuj Goel; John Peden; Anders Mälarstig; Gabrielle Paulsson-Berne; Anders Hamsten; Anders Franco-Cereceda; Anders Gabrielsen; Per Eriksson Journal: PLoS One Date: 2009-11-02 Impact factor: 3.240
Authors: Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312
Authors: Hetal S Shah; He Gao; Mario Luca Morieri; Jan Skupien; Skylar Marvel; Guillaume Paré; Gaia C Mannino; Patinut Buranasupkajorn; Christine Mendonca; Timothy Hastings; Santica M Marcovina; Ronald J Sigal; Hertzel C Gerstein; Michael J Wagner; Alison A Motsinger-Reif; John B Buse; Peter Kraft; Josyf C Mychaleckyj; Alessandro Doria Journal: Diabetes Care Date: 2016-08-15 Impact factor: 19.112